Randomized, Double-Blinded, Placebo-Controlled, Multiple Ascending Dose Study to Compare the Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects.

Trial Profile

Randomized, Double-Blinded, Placebo-Controlled, Multiple Ascending Dose Study to Compare the Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Opicapone (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors Bial
  • Most Recent Events

    • 01 Mar 2016 Results (n=105) published in the Clinical Pharmacology in Drug Development.
    • 20 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
    • 19 Feb 2013 Planned End Date changed from 1 Dec 2012 to 1 Jun 2013, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top